AllianceBernstein’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$303K Hold
213,590
﹤0.01% 2874
2025
Q4
$303K Hold
213,590
﹤0.01% 2898
2025
Q3
$350K Hold
213,590
﹤0.01% 2868
2025
Q2
$156K Buy
213,590
+25,180
+13% +$21.7K ﹤0.01% 3105
2025
Q1
$152K Hold
188,410
﹤0.01% 2990
2024
Q4
$260K Hold
188,410
﹤0.01% 2944
2024
Q3
$196K Hold
188,410
﹤0.01% 3042
2024
Q2
$326K Buy
188,410
+41,910
+29% +$84.3K ﹤0.01% 2883
2024
Q1
$350K Sell
146,500
-9,500
-6% -$23.4K ﹤0.01% 2746
2023
Q4
$519K Hold
156,000
﹤0.01% 2594
2023
Q3
$583K Sell
156,000
-30,520
-16% -$141K ﹤0.01% 2501
2023
Q2
$796K Sell
186,520
-5,950,405
-97% -$35.1M ﹤0.01% 2399
2023
Q1
$42M Sell
6,136,925
-80,633
-1% -$626K 0.02% 611
2022
Q4
$49.2M Buy
6,217,558
+110,697
+2% +$852K 0.02% 581
2022
Q3
$58.7M Buy
6,106,861
+431,412
+8% +$4.37M 0.03% 496
2022
Q2
$41.1M Sell
5,675,449
-138,175
-2% -$1.2M 0.02% 622
2022
Q1
$75.1M Buy
5,813,624
+105,916
+2% +$1.35M 0.03% 491
2021
Q4
$91.1M Buy
5,707,708
+1,117,972
+24% +$19.6M 0.03% 463
2021
Q3
$73.8M Buy
4,589,736
+85,462
+2% +$1.25M 0.03% 509
2021
Q2
$62.3M Buy
4,504,274
+308,905
+7% +$4.37M 0.03% 548
2021
Q1
$61.3M Sell
4,195,369
-508,831
-11% -$8.64M 0.03% 549
2020
Q4
$81.8M Buy
4,704,200
+192,961
+4% +$3.44M 0.04% 437
2020
Q3
$82.7M Buy
4,511,239
+395,787
+10% +$7.36M 0.04% 385
2020
Q2
$73.5M Buy
4,115,452
+889,128
+28% +$15M 0.04% 414
2020
Q1
$52.3M Buy
3,226,324
+1,048,294
+48% +$19.4M 0.04% 427
2019
Q4
$39.2M Buy
2,178,030
+1,623,851
+293% +$29.9M 0.02% 606
2019
Q3
$11.2M Buy
554,179
+463,479
+511% +$9.26M 0.01% 1001
2019
Q2
$2M Buy
90,700
+19,500
+27% +$339K ﹤0.01% 1972
2019
Q1
$971K Hold
71,200
﹤0.01% 2247
2018
Q4
$644K Hold
71,200
﹤0.01% 2378
2018
Q3
$1.18M Buy
71,200
+2,200
+3% +$39K ﹤0.01% 2249
2018
Q2
$966K Buy
69,000
+34,280
+99% +$491K ﹤0.01% 2332
2018
Q1
$384K Buy
34,720
+6,000
+21% +$65.6K ﹤0.01% 2604
2017
Q4
$253K Hold
28,720
﹤0.01% 2783
2017
Q3
$383K Sell
28,720
-7,800
-21% -$103K ﹤0.01% 2671
2017
Q2
$524K Buy
36,520
+7,100
+24% +$137K ﹤0.01% 2595
2017
Q1
$622K Sell
29,420
-3,500
-11% -$86.1K ﹤0.01% 2457
2016
Q4
$927K Hold
32,920
﹤0.01% 2293
2016
Q3
$882K Hold
32,920
﹤0.01% 2289
2016
Q2
$556K Buy
32,920
+4,700
+17% +$88.2K ﹤0.01% 2481
2016
Q1
$599K Sell
28,220
-5,900
-17% -$96.7K ﹤0.01% 2347
2015
Q4
$783K Hold
34,120
﹤0.01% 2252
2015
Q3
$684K Buy
34,120
+820
+2% +$25K ﹤0.01% 2358
2015
Q2
$962K Buy
33,300
+26,800
+412% +$677K ﹤0.01% 2303
2015
Q1
$199K Buy
+6,500
New +$168K ﹤0.01% 2833

Other funds holding CHRS